Nov 22, 2004 by Brian GormanBoeing in a Holding PatternThe company's stock seems fairly valued with all the uncertainty in the air.
Nov 19, 2004 by Brian GormanGoogle's CautionGoogle's warning is no reason to panic, though the Internet upstart's position is not as secure as it once was.
Nov 17, 2004 by Brian GormanDays of Wine and Roses1-800-Flowers.com's move into wine seems to have real promise.
Nov 16, 2004 by Brian GormanCKE's MonsterThe restaurant company may be bumping up against the limits of its Thickburger line.
Nov 15, 2004 by Brian GormanFord's First StepIf the automaker hopes to reverse its market slide, this year better be just the beginning of its efforts.
Nov 12, 2004 by Brian GormanTarget Can Aim HighTarget can maintain its discount image while offering pricier services and merchandise.
Nov 11, 2004 by Brian GormanHospira's PossibilitiesThe company is not flashy, but it may benefit from long-term trends.
Nov 10, 2004 by Brian GormanAmazon's Silver ScreenThis new marketing initiative shows that companies are eager to use broadband media. But how?
Nov 9, 2004 by Brian GormanCocoa Crisis?Unrest in the Ivory Coast could mean trouble for companies that need chocolate.
Nov 8, 2004 by Brian GormanPfizer's Gloom FactorThe stock will continue to be depressed, but things will improve if Celebrex's safety is proven.
Nov 5, 2004 by Brian GormanAlcan Shows Its MettleAlcan produces an impressive third quarter and prepares to unlock shareholder value.
Nov 4, 2004 by Brian GormanDean Wrestles With PicklesThe company struggled in the third quarter as inflationary pressures took their toll.
Nov 3, 2004 by Brian GormanYahoo! Concentrates on the CreativeThe company's hiring of Lloyd Braun may mean that it wants to be more involved in original content.
Nov 2, 2004 by Brian GormanaaiPharma Steadies ItselfInvestors applauded aaiPharma's restructuring, but the company has plenty of challenges ahead.
Nov 1, 2004 by Brian GormanBristol-Myers Stays the CourseBristol-Myers remains downbeat on its outlook through 2006, but two promising compounds could lift the pharmaceutical company's fortunes.
Oct 29, 2004 by Brian GormanElan Bides Its TimeIs the company stronger from its near-death experience?
Oct 28, 2004 by Brian GormanCardinal's Good News: No NewsCardinal Health took a major step toward rehabilitating itself with the release of its 10-K.
Oct 27, 2004 by Brian GormanCoke's Misspent EnergyThe company needs to focus on its core brand rather than launching new products.
Oct 26, 2004 by Brian GormanYahoo! Gets Adobe in Its CornerYahoo! makes alliances to fend off Google.
